|
|||||
|
|
Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists II: Tuning of receptor selectivity and in vivo efficacy |
|
| Authors: | Marna Pippel Kristen Boyce Hariharan Venkatesan Victor K. Phuong Wen Yan Terrance D. Barrett Guy Lagaud Lina Li Magda F. Morton Clodagh Prendergast Xiaodong Wu Nigel P. Shankley Michael H. Rabinowitz |
| Affiliation: | aJohnson & Johnson Pharmaceutical Research and Development, L.L.C., 3210 Merryfield Row, San Diego, CA 92121, United States |
| Abstract: | In the previous article we demonstrated how certain CCK2R-selective anthranilic amides could be structurally modified to afford high-affinity, selective CCK1R activity. We now describe our efforts at modulating and optimizing the CCK1R and CCK2R affinities aimed at producing compounds with good pharmacokinetics properties and in vivo efficacy in rat models of gastric acid and pancreatic amylase secretion. |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |